Skip to content

No difference in post-liver transplant survival between HAART-treated HIV-positive and HIV-negative

HAART does not fully restore brain impairment due to HIV

Cost of care shown to be primary barrier to adherence in African study

High rates of AIDS and death in first year of life argue for universal ART for kids with HIV

Brazil wins 75% discount on new HIV drug

How will AZT and nevirapine use for MTCT affect future treatment? Two studies provide clues

Total lymphocyte count predicts risk of death in children

Second English HIV transmission prosecution rings alarm bells

NNRTI-based HAART associated with quicker CD4 cell gains than PI-based therapy